The University of Southampton
University of Southampton Institutional Repository

The assessment of sperm velocity and prolactin in the infertile male

The assessment of sperm velocity and prolactin in the infertile male
The assessment of sperm velocity and prolactin in the infertile male

The first part of the study comprises the development of a method of measuring sperm velocity (p=/sec) by time-lapse photography (TLP). Recordings were performed in 50 infertile men and compared to 20 fertile men. TLP was found to be an accurate method of measuring sperm velocity with a low coefficient of variation. Its accuracy is limited at low sperm density levels (less than 5 million/ml). Sperm velocity is a separate parameter from percentage motility and sperm density. It is not dependent on serum hormonal levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), 17p oestradiol and dihydrotestosterone (DHT). A statistically significant difference in sperm velocity was found between the two groups studied and no fertile male had a sperm velocity of less than 30 µm/sec. The importance of sperm velocity as a new parameter in the investigation of male infertility is discussed. A statistically significant difference in the levels of serum 17p oestradiol was also noted between fertile and infertile men. The second part studies the role of serum prolactin in spermatogenesis using the same infertile (50) and fertile (20) patients. There was no statistical difference in either serum or seminal prolactin between the two grcups. In the infertile patients FSH levels were found to correlate with prolactin at both serum and seminal levels. Serum LH was also correlated with seminal prolactin. No such correlations were found in the fertile group. The 50 infertile patients were randomly separated into two groups and received Bromocriptine 2.5 mg b.d. or placebo on a double-blind parallel group basis. The patients were re-assessed after three and six months treatment. Bromocriptine is an effective prolactin-lowering agent at both set- and seminal level. Bromocriptine has a deleterious effect on sperm production and no apparent effect on androgen metabolism. Dihydrotestosterone (DHT) progressively rose in both placebo and Bromocriptine treated groups and it is suggested that this might explain the apparent beneficial effect on spermatogenesis by placebo noted in other series.

University of Southampton
Milligan, Michael Peter
Milligan, Michael Peter

Milligan, Michael Peter (1981) The assessment of sperm velocity and prolactin in the infertile male. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

The first part of the study comprises the development of a method of measuring sperm velocity (p=/sec) by time-lapse photography (TLP). Recordings were performed in 50 infertile men and compared to 20 fertile men. TLP was found to be an accurate method of measuring sperm velocity with a low coefficient of variation. Its accuracy is limited at low sperm density levels (less than 5 million/ml). Sperm velocity is a separate parameter from percentage motility and sperm density. It is not dependent on serum hormonal levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), 17p oestradiol and dihydrotestosterone (DHT). A statistically significant difference in sperm velocity was found between the two groups studied and no fertile male had a sperm velocity of less than 30 µm/sec. The importance of sperm velocity as a new parameter in the investigation of male infertility is discussed. A statistically significant difference in the levels of serum 17p oestradiol was also noted between fertile and infertile men. The second part studies the role of serum prolactin in spermatogenesis using the same infertile (50) and fertile (20) patients. There was no statistical difference in either serum or seminal prolactin between the two grcups. In the infertile patients FSH levels were found to correlate with prolactin at both serum and seminal levels. Serum LH was also correlated with seminal prolactin. No such correlations were found in the fertile group. The 50 infertile patients were randomly separated into two groups and received Bromocriptine 2.5 mg b.d. or placebo on a double-blind parallel group basis. The patients were re-assessed after three and six months treatment. Bromocriptine is an effective prolactin-lowering agent at both set- and seminal level. Bromocriptine has a deleterious effect on sperm production and no apparent effect on androgen metabolism. Dihydrotestosterone (DHT) progressively rose in both placebo and Bromocriptine treated groups and it is suggested that this might explain the apparent beneficial effect on spermatogenesis by placebo noted in other series.

This record has no associated files available for download.

More information

Published date: 1981

Identifiers

Local EPrints ID: 459561
URI: http://eprints.soton.ac.uk/id/eprint/459561
PURE UUID: 40a14ed6-83b5-4168-87e9-3cfab6bec44f

Catalogue record

Date deposited: 04 Jul 2022 17:14
Last modified: 04 Jul 2022 17:14

Export record

Contributors

Author: Michael Peter Milligan

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×